Concepedia

Nicolas Gazeau

NG

Statistics

Publications

7

Citations

332

H-Index

7

Active since

2021

Affiliations

Fred Hutch Cancer Center(Current)

Centre Hospitalier Universitaire de Lille

University of Washington

Oregon Health & Science University

Inserm

Nicolas Gazeau is an author at Fred Hutch Cancer Center specializing in chimeric antigen receptor t-cell therapy, immunotherapy, and life sciences.

ORCID

Publications per year

2021–2025

7

Publications

7

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Nicolas Gazeau, Emily C. Liang, Qian Wu et al. · Transplantation and Cellular Therapy · 2023 · 135 citations · Full text

, , +12

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Jordan Gauthier, Nicolas Gazeau, Alexandre V. Hirayama et al. · Blood · 2022 · 54 citations · Full text

, , +13

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright et al. · Blood Advances · 2023 · 53 citations · Full text

, , +17

Effective anti-BCMA retreatment in multiple myeloma

Nicolas Gazeau, David Beauvais, Ibrahim Yakoub‐Agha et al. · Blood Advances · 2021 · 45 citations · Full text

, , +17

Safety and Efficacy of Two Anakinra Dose Regimens for Refractory CRS or Icans after CAR T-Cell Therapy

Nicolas Gazeau, Pere Barba, Gloria Iacoboni et al. · Blood · 2021 · 18 citations

, , +15

1–5 of 7